OverviewSuggest Edit

VBL Therapeutics is a biopharmaceutical company focused on the development of treatments for cancer. It offers VB-111, a gene-based biologic agent for solid tumor indications for ovarian cancer, recurrent glioblastoma, colon cancer, and thyroid cancer.
TypePublic
Founded2000
HQModi'in-Maccabim-Re'ut, IL
Websitevblrx.com

Latest Updates

Employees (est.) (Jul 2021)38
Share Price (Aug 2021)$2.1(-1%)
Cybersecurity ratingBMore

Vascular Biogenics Office Locations

Vascular Biogenics has an office in Modi'in-Maccabim-Re'ut
Modi'in-Maccabim-Re'ut, IL (HQ)
Ha-Satat St 8
Show all (1)

Vascular Biogenics Financials and Metrics

Vascular Biogenics Revenue

Market capitalization (3-Aug-2021)

126.0m

Closing stock price (3-Aug-2021)

2.1
Vascular Biogenics's current market capitalization is $126 m.
Show all financial metrics

Vascular Biogenics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Vascular Biogenics Online and Social Media Presence

Embed Graph

Vascular Biogenics News and Updates

Thinking about buying stock in Xeris Pharmaceuticals, Acutus Medical, Vascular Biogenics, Nokia, or TAL Education Group?

NEW YORK, July 19, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XERS, AFIB, VBLT, NOK, and TAL. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Vascular Biogenics, Ltd. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses Investors can contact the law firm at no cost to learn more about recovering their losses

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vascular Biogenics Ltd. - VBLT

NEW YORK, June 16, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vascular Biogenics Ltd. ("VBL" or the "Company") (NASDAQ: VBLT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The...

Vascular Biogenics Ltd. Closes Public Offering of Ordinary Shares and Pre-Funded Warrants

TEL AVIV, Israel, April 14, 2021 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT), today announced the closing of its underwritten public offering of 6,901,790 ordinary shares, and, to certain investors in lieu thereof, pre-funded warrants to purchas…

Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants

TEL AVIV, Israel, April 09, 2021 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT), today announced the pricing of an underwritten public offering of 5,150,265 ordinary shares and, to certain investors in lieu thereof, pre-funded warrants to purchase …

Vascular Biogenics Ltd. Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

TEL AVIV, Israel, April 08, 2021 (GLOBE NEWSWIRE) -- Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT), today announced that it intends to offer and sell ordinary shares and, to certain investors in lieu thereof, pre-funded warrants to purchase ordinary shares in an unde…
Show more

Vascular Biogenics Frequently Asked Questions

  • When was Vascular Biogenics founded?

    Vascular Biogenics was founded in 2000.

  • How many employees does Vascular Biogenics have?

    Vascular Biogenics has 38 employees.

  • Who are Vascular Biogenics competitors?

    Competitors of Vascular Biogenics include Jiangsu Hansoh Pharmaceutical Group, 3sbio and Kyowa Kirin.

  • Where is Vascular Biogenics headquarters?

    Vascular Biogenics headquarters is located at Ha-Satat St 8, Modi'in-Maccabim-Re'ut.

  • Where are Vascular Biogenics offices?

    Vascular Biogenics has an office in Modi'in-Maccabim-Re'ut.

  • How many offices does Vascular Biogenics have?

    Vascular Biogenics has 1 office.